Entrada Therapeutics, Inc. — Investor Relations & Filings
Entrada Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing a new class of medicines to treat devastating diseases. The company's proprietary Endosomal Escape Vehicle (EEV) platform is designed to enable the intracellular delivery of a wide range of therapeutics, allowing access to targets that have historically been considered undruggable. Entrada's development pipeline is concentrated on rare conditions, with programs targeting neuromuscular diseases, including Duchenne muscular dystrophy, as well as ocular diseases. The company's mission is to transform the lives of patients by establishing EEV-based therapeutics as a new treatment modality.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM 4 | 2024-06-14 | English | |
| FORM 4 | 2024-06-14 | English | |
| FORM 4 | 2024-06-14 | English | |
| FORM 4 | 2024-06-14 | English | |
| Regulatory Filings 2024 | 2024-06-13 | English | |
| FORM 8-K | 2024-06-13 | English |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2024
15 filings
| |||||
| 12990102 | FORM 4 | 2024-06-14 | English | ||
| 12990103 | FORM 4 | 2024-06-14 | English | ||
| 12990104 | FORM 4 | 2024-06-14 | English | ||
| 12990105 | FORM 4 | 2024-06-14 | English | ||
| 12990107 | Regulatory Filings 2024 | 2024-06-13 | English | ||
| 12990109 | FORM 8-K | 2024-06-13 | English | ||
| 12990110 | FORM 4 | 2024-06-05 | English | ||
| 12990111 | FORM 4 | 2024-05-20 | English | ||
| 12990113 | FORM 4 | 2024-05-20 | English | ||
| 12990114 | FORM 4 | 2024-05-16 | English | ||
| 12990115 | Regulatory Filings 2024 | 2024-05-16 | English | ||
| 12990116 | Regulatory Filings 2024 | 2024-05-16 | English | ||
| 12990117 | FORM 4 | 2024-05-10 | English | ||
| 12990122 | 10-Q | 2024-05-07 | English | ||
| 12990124 | 8-K | 2024-05-07 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Entrada Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33674/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33674 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33674 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33674 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33674}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Entrada Therapeutics, Inc. (id: 33674)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.